Among the top 10 regulatory kinases, only CHEK2 and nemo-like kinase (NLK) had a significant impact on outcome in patients with rectal cancer (Figure 9(d)); of note, none of these kinases had a significant influence on the outcome of patients with colon cancer. This evidence concerns the gene CHEK2 and malignant colon neoplasm.